- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Connect Biopharma links to $115m
Lilly Asia Ventures was among the new investors in a series C round for autoimmune and inflammatory disease drug developer Connect Biopharma.
Aug 25, 2020TearClear picks out $22m series B
TearClear has raised $34.8m to date to fund an anti-preservative eye drop technology invented at University of Florida.
Aug 25, 2020Outset Medical touts IPO intentions
Baxter Ventures is set to exit the kidney dialysis device maker, which has just filed to go public following upwards of $430m in venture funding.
Aug 25, 2020FarEye fattens up series D round
The predictive logistics platform developer has raised a further $13m, adding to $24.5m raised from investors including M12 and Honeywell Ventures in April.
Aug 25, 2020Yidu Tech speeds toward public markets
The medical data software producer has filed to float in Hong Kong after raising nearly $340m from investors including Tencent and Sunshine Insurance.
Aug 25, 2020Daily deal net: August 24, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 24, 2020Nano-X nabs $165m in initial public offering
The SK Telecom, iA Financial, Foxconn and Fujifilm-backed X-ray technology developer priced the offering at the top of its range.
Aug 24, 2020Kymera climbs to $174m IPO
The protein degradation drug developer's valuation has rocketed following an offering that achieved exits for Vertex Pharmaceuticals, Pfizer, Sanofi, Amgen and Merck & Co.
Aug 24, 2020Dataiku documents $100m series D round
CapitalG, which joined Dataiku’s shareholders through a secondary transaction last year, has now made its first primary investment in the data management software provider.
Aug 24, 2020Lambda School lands $74m
Gigafund led a series C round for the GV and Stripe-backed online coding school to increase its overall funding to approximately $122m.
Aug 24, 2020Exo extracts $40m from investors
GlaxoSmithKline’s Action Potential Venture Capital fund led a series B-plus round that included TDK Ventures, Intel Capital and Applied Ventures.
Aug 24, 2020Corporates explore iSpace in $28m series B
Takasago Thermal Engineering and Mitsui Sumitomo Insurance made strategic investments in the moon exploration business, which has now raised $125m in total.
Aug 24, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


